Mozobil (plerixafor injection)
Genzyme Corp (Cambridge, MA) recently received FDA
approval to market Mozobil, a hematopoietic stem cell mobilizer.
The drug is indicated in combination with granulocytecolony
stimulating factor (G-CSF) to mobilize hematopoietic
stem cells to the peripheral blood for collection and subsequent
autologous transplantation in patients with non-Hodgkin's
lymphoma and multiple myeloma. Clinicians should initiate
Mozobil treatment after the patient has received G-CSF
once daily for 4 days. The product should be administered
approximately 11 hours prior to initiation of apheresis for up
to 4 consecutive days. The recommended dose of Mozobil is
0.24 mg/kg body weight by subcutaneous injection. If creatinine
clearance is =50 mL/min, decrease dose by one third to
0.16 mg/kg. Mozobil is supplied as a single-use vial containing
1.2 mL of a 20-mg/mL solution. For more information, visit
www.mozobil.com, or call 877-4MOZOBIL.
RiaSTAP
CSL Behring's (King of Prussia, PA) RiaSTAP was recently
licensed by the FDA. RiaSTAP, Fibrinogen Concentrate
(Human) is indicated for the treatment of acute bleeding
episodes in patients with congenital fibrinogen deficiency,
including afibrinogenemia and hypofibrinogenemia.
Individuals with congenital fibrinogen are unable to make
sufficient amounts of fibrinogen, which plays an important
role in blood coagulation by helping to form blood clots and
prevent bleeding. RiaSTAP dosing, duration of dosing, and
frequency of administration should be individualized based
on the extent of bleeding, laboratory values, and clinical
condition of the patient. The product is available as a singleuse
vial containing 900 mg to 1300 mg lyophilized fibrinogen
concentrate powder for reconstitution with 50 mL of sterile
water for injection. For more information, visit www.riastap.
com, or call 888-508-6978.
Rapid-Fill Automated Syringe Filler
Baxa Corp (Englewood, CO) recently announced the addition
of colored syringe labels to its Rapid-Fill Automated
Syringe Filler offering. The Rapid-Fill is accurate, easy-touse,
safe, and efficient automation for intravenous syringe
filling. The system reduces pharmacy overhead for batching
activities, while providing the opportunity for more adequate
staff allocation and greater inventory control. The syringe
labels are available in 8 new colors, in addition to the original
white, that allow health care professionals to extend the
Rapid-Fill Automated Syringe Filler automation to broader
applications in pharmacy filling. The company has added 8
color labels to its product line for use in anesthesia applications.
The new labels expand the potential uses of the unique
Rapid-Fill product for hospital pharmacies by reducing the
workload involved in sterile filling and labeling of anesthetic
drugs. For more information, visit
www.baxa.com, or call
800-567-BAXA (800-567-2292).
Identification Bands, Pens, and Surgical
Skin Markers
 |
EPS Inc (Ivyland, PA) recently introduced a line of Identification
Bands, Pens, and Surgical Skin Markers to enhance
medication and patient identification. The Identification
Bands are available in both Mother/Infant and Mother/
Father/Infant styles. The matching serial numbers ensure
that the infant and parents are properly correlated. The extra
soft plastic and nonirritating snap provides comfort for both
parents and children. The bands are available in 3-part and
4-part styles in white, pink, or blue and are ideal for use with
any identification band. The permanent ink is resistant to
water, alcohol, and smears. The product is available in blue,
green, red, and black and can be used to mark materials and
supplies throughout the hospital. The Surgical Skin Markers
are available in both sterile and nonsterile styles. The sterile
pens are packaged in plastic, in a peel-down, nonfiber shedding
package, specifically designed for use in sterile fields.
Available with labels and rulers, all Surgical Skin Markers
use a nontoxic gentian violet ink. For more information, visit
www.medidose.com, or call 800-523-8966.
